Incorporation of biological information in cancer risk assessment: Example — Vinyl chloride

Vinyl chloride (VC) is used as an example to demonstrate how biological information can be incorporated into quantitative risk assessment. The information included is the pharmacokinetics of VC in animals and humans and the data-generated hypothesis that VC primarily affects the initiation stage of the multistage carcinogenesis. The emphasis in this paper is on the improvement of risk assessment methodology rather than the risk assessment of VC per se.Sufficient data are available to construct physiologically-based pharmacokinetic models for both animals and humans. These models are used to calculate the metabolized dose corresponding to exposure scenarios in animals and in humans.On the basis of the data on liver angiosarcomas and carcinomas in rats, the cancer risk per unit of metabolized dose is comparable, irrespective of routes (oral or inhalation) of exposure. The tumor response from an intermittent/partial lifetime exposure is shown to be consistent with that from a lifetime exposure when VC is assumed to affect the first (initiation) stage of the multistage carcinogenic process. Furthermore, the risk estimates calculated on the basis of animal data are shown to be consistent with the human experience.

[1]  P. Watanabe,et al.  Risk of angiosarcoma in workers exposed to vinyl chloride as predicted from studies in rats. , 1979, Toxicology and applied pharmacology.

[2]  S H Moolgavkar,et al.  Mutation and cancer: a model for human carcinogenesis. , 1981, Journal of the National Cancer Institute.

[3]  H. Bolt,et al.  Inhalation pharmacokinetics based on gas uptake studies , 1981, Archives of Toxicology.

[4]  M E Andersen,et al.  Determination of the kinetic constants for metabolism of inhaled toxicants in vivo using gas uptake measurements. , 1980, Toxicology and applied pharmacology.

[5]  H. Bolt,et al.  Pharmacokinetics of vinyl chloride in the Rhesus monkey. , 1980, Toxicology letters.

[6]  C F Hendriksen,et al.  Lifespan oral toxicity study of vinyl chloride in rats. , 1981, Food and cosmetics toxicology.

[7]  P. Watanabe,et al.  Resolution of dose-response toxicity data for chemicals requiring metabolic activation: example--vinyl chloride. , 1978, Toxicology and applied pharmacology.

[8]  H. Bolt,et al.  Pharmacokinetics of halogenated ethylenes in rats , 1978, Archives of Toxicology.

[9]  S. Moolgavkar,et al.  Two-event models for carcinogenesis: incidence curves for childhood and adult tumors☆ , 1979 .

[10]  H. Bolt,et al.  Inhalation pharmacokinetics based on gas uptake studies , 1983, Archives of Toxicology.

[11]  R. E. Greenfield,et al.  A general probabilistic model of carcinogenesis: analysis of experimental urinary bladder cancer. , 1984, Carcinogenesis.

[12]  H. Bolt,et al.  Pharmacokinetics of vinyl chloride in the rat. , 1977, Toxicology.

[13]  M E Andersen,et al.  A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. , 1984, Toxicology and applied pharmacology.

[14]  A. Holmes,et al.  Mortality experience of workers exposed to vinyl chloride monomer in the manufacture of polyvinyl chloride in Great Britain. , 1977, British journal of industrial medicine.

[15]  P. Watanabe,et al.  Comparison of the fate of vinyl chloride following single and repeated exposure in rats. , 1978, Toxicology and applied pharmacology.

[16]  P. Watanabe,et al.  Fate of (14C)vinyl chloride after single oral administration in rats. , 1976, Toxicology and applied pharmacology.

[17]  K. G. Brown,et al.  Statistical modeling of animal bioassay data with variable dosing regimens: example--vinyl chloride. , 1986, Risk analysis : an official publication of the Society for Risk Analysis.

[18]  A. Whittemore The age distribution of human cancer for carcinogenic exposures of varying intensity. , 1977, American journal of epidemiology.

[19]  P. Armitage,et al.  The Age Distribution of Cancer and a Multi-stage Theory of Carcinogenesis , 1954, British Journal of Cancer.

[20]  Chu Kc,et al.  Implications of the multistage theory of carcinogenesis applied to occupational arsenic exposure. , 1983 .

[21]  D G Hoel,et al.  A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: example--vinyl chloride. , 1980, Toxicology and applied pharmacology.

[22]  S. Moolgavkar Carcinogenesis modeling: from molecular biology to epidemiology. , 1986, Annual review of public health.

[23]  H. Bolt,et al.  Binding kinetics of vinyl chloride and vinyl bromide at very low doses. , 1980, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[24]  R H Reitz,et al.  Non-linear pharmacokinetic parameters need to be considered in high dose/low dose extrapolation. , 1980, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[25]  J. Withey Pharmacodynamics and uptake of vinyl chloride monomer administered by various routes to rats. , 1976, Journal of toxicology and environmental health.

[26]  C. Paúl,et al.  Education, leisure activities and cognitive and functional ability of Alzheimer's disease patients: A follow-up study , 2013, Dementia & neuropsychologia.

[27]  C. Maltoni,et al.  Carcinogenicity bioassays of vinyl chloride monomer: a model of risk assessment on an experimental basis. , 1981, Environmental health perspectives.

[28]  P. Watanabe,et al.  Hepatic macromolecular binding following exposure to vinyl chloride. , 1978, Toxicology and applied pharmacology.

[29]  Kenny S. Clump,et al.  The Multistage Model with a Time‐Dependent Dose Pattern: Applications to Carcinogenic Risk Assessment1 , 1984 .

[30]  J. Haseman,et al.  The effect of age and exposure duration on cancer induction by a known carcinogen in rats, mice, and hamsters. , 1983, Toxicology and applied pharmacology.

[31]  P. Armitage,et al.  Multistage models of carcinogenesis. , 1985, Environmental health perspectives.

[32]  J. Winston,et al.  Follow-up study on the carcinogenicity of vinyl chloride and vinylidene chloride in rats and mice: tumor incidence and mortality subsequent to exposure. , 1981, Journal of toxicology and environmental health.